Home
News
- 1 AstraZeneca share price increased by 0.30% over the past seven days.
- 2 AstraZeneca Plc. ( LSE: AZN) stock’s 52-week price range is £100 – £123.
AstraZeneca has been increasing its earnings by 5.3% yearly on average, matching the growth rate of the Pharmaceuticals industry, according to the financial website Simply Wall St. The company’s revenues have also been rising by 17.6% annually on average. AstraZeneca has a net margin of 13.9% and a return on equity of 16.5%.
Simply Wall St. shows that AstraZeneca has a debt-to-equity ratio of 79.8%, which is calculated from its total shareholder equity of £37.4 Billion and total debt of £29.8 Billion. The company’s total assets and total liabilities are £96.5 Billion and £59.1 Billion, respectively. AstraZeneca’s EBIT is £12.9 Billion making its interest coverage ratio 14.6. It has cash and short-term investments of £5.8 Billion.
The market capitalization of AZN share is £173.525 Billion, and the total revenue is £36.006 Billion. Moreover, the stock’s basic EPS is £4, and the price-to-earnings ratio is 34. Moreover, the average volume is 1.74 Million, and the current volume is 188.453K. The current volume is below average volume.
Moreover, the stock has not done well in the last three months, decreasing by 8.57%, and it has surged by 5.66% in the last six months. However, AstraZeneca Plc. (LSE: AZN) the stock has a negative year-to-date return of 4.08% and a positive 1-year return of 1.93%.
Technical Analysis of Astrazeneca Share Price in 1-D Timeframe
The price action shows that AstraZeneca Plc’s ( LSE: AZN) stock price has been on a rising trend for the last month, increasing by 4.79%. At the time of writing, AZN share is trading at £108.52 and has violated making higher highs and lows and took a pullback.
Therefore, if it maintains the current level, the AZN price could continue to move upwards and reach the first and second targets of £113.58 and £118.34. However, if the AZN price fails to sustain the current level and drops, then it might hit the nearest support levels of £106.44 and £101.54.
At the time of publishing, AstraZeneca PLC. (LSE: AZN) is trading below the 50, 100, and 200-day EMAs (exponential moving averages), which are rejecting the price trend.
However, 20-day EMA is supporting the trend. If more buying volume adds up, then the price might conquer rejecting EMA’s by making higher highs and lows.
Hence, AZN price is expected to move upwards, giving bullish views over the daily time frame chart.
The current value of RSI is 49.46 points. The 14 SMA is below the median line at 61.08 points which indicates that AstraZeneca share is neutral.
The MACD line at 0.1302 and signal line at 0.8111 are above the zero line, and both lines are closing in on each other. A bullish crossover is observed in the MACD oscillator, which signals more bullishness for the AZN share price.
Summary
AstraZeneca PLC. (LSE: AZN) indicates that the investors and traders of the stock price are bullish on the 1-D time frame. The price action reflects a bullish outlook at the time of publishing. The technical oscillators of the AZN share price also support the bullish trend. The MACD, RSI, and EMA are highlighting positive signals and imply that the uptrend may continue in the AZN share price.
Technical Levels
- The nearest support levels for AstraZeneca’s share price are £106.44 and £101.54.
- The nearest resistance levels for AstraZeneca’s share price are £113.58 and £118.34.
Disclaimer
In this article, the views and opinions stated by the author or any people named are for informational purposes only, and they don’t establish the investment, financial, or any other advice. Trading or investing in cryptocurrency assets comes with a risk of financial loss.
With a background in journalism, Ritika Sharma has worked with many reputed media firms focusing on general news such as politics and crime. She joined The Coin Republic as a reporter for crypto, and found a great passion for cryptocurrency, Web3, NFTs and other digital assets. She spends a lot of time researching and delving deeper into these concepts around the clock, and is a strong advocate for women in STEM.
